본문으로 건너뛰기
← 뒤로

Emerging insights into cell differentiation: the role of N-glycosylation in differentiation-based cancer therapies.

1/5 보강
Carbohydrate research 2026 Vol.560() p. 109787
Retraction 확인
출처

Wu T, Ye P, Yang J, Sun Y

📝 환자 설명용 한 줄

N-glycosylation is a dynamic post-translational modification that critically regulates cancer cell differentiation through modulating receptor signaling, cell adhesion, and plasticity.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Wu T, Ye P, et al. (2026). Emerging insights into cell differentiation: the role of N-glycosylation in differentiation-based cancer therapies.. Carbohydrate research, 560, 109787. https://doi.org/10.1016/j.carres.2025.109787
MLA Wu T, et al.. "Emerging insights into cell differentiation: the role of N-glycosylation in differentiation-based cancer therapies.." Carbohydrate research, vol. 560, 2026, pp. 109787.
PMID 41351999 ↗

Abstract

N-glycosylation is a dynamic post-translational modification that critically regulates cancer cell differentiation through modulating receptor signaling, cell adhesion, and plasticity. Aberrant N-glycosylation promotes dedifferentiation, drives EMT, and confers therapy resistance across malignancies. This review summarizes the role of N-glycosylation in determining lineage commitment and altering responses to differentiation therapies. Targeting the N-glycosylation apparatus can reprogram tumor cells toward differentiated phenotypes, potentiating the effects of agents such as ATRA and NaBu. Evidence from leukemia and solid tumors reveals the therapeutic potential of disrupting glycan-dependent cell fate decisions. Deciphering these "glycan codes" provides a framework for integrating glycosylation modifiers into precision differentiation therapies, offering novel strategies to overcome treatment resistance.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반